Eindhoven (NL)/Zurich (CH), 14th February 2020 - Clinical trial results of Xeltis pulmonary valve (PV) show promising functionality of the living valves developed in patients as a result of its restorative implants. The recent trial data have been presented today at the International Conference of Tissue-Engineered Heart Valves (ICTEHV) as part of the 2020 Heart Valve Society scientific meeting. The data showed promising outcomes of Xeltis pulmonary valve at one-year follow-up in six U.S. pediatric patients and two-year follow-up in 12 pediatric patients enrolled in EU and Asian trial sites. [...]